Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients with Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial

Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesHeart Failure
Do you want to read an article? Please log in or register.